Drug Type AAV based gene therapy |
Synonyms |
Target |
Action modulators |
Mechanism APOC3 modulators(Apolipoprotein C-III modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemophilia B | Preclinical | South Korea | 21 Dec 2023 |